Hanson McClain Advisors »

Fennec Pharmaceuticals shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $141 23 6.17

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds State Street Spd (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Hanson McClain Advisors

Top funds holding Fennec Pharmaceuticals

Rosalind Advisors
Southpoint Capital Advisors
Solas Capital Management
AIGH Capital Management
BlackRock
Vanguard Capital Management
AWM Investment Company
Geode Capital Management
State Street Corporation
Potomac Capital Management
Morgan Stanley
Vanguard Portfolio Management
Citadel Advisors
Northern Trust
Lion Point Capital

View all funds holding Fennec Pharmaceuticals